These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27856346)

  • 21. Endomorphins: potential roles and therapeutic indications in the development of opioid peptide analgesic drugs.
    Liu WX; Wang R
    Med Res Rev; 2012 May; 32(3):536-80. PubMed ID: 21287571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptidomimetics: An Overview of Recent Medicinal Chemistry Efforts toward the Discovery of Novel Small Molecule Inhibitors.
    Li Petri G; Di Martino S; De Rosa M
    J Med Chem; 2022 Jun; 65(11):7438-7475. PubMed ID: 35604326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptides and peptidomimetics that behave as low molecular weight gelators.
    Tomasini C; Castellucci N
    Chem Soc Rev; 2013 Jan; 42(1):156-72. PubMed ID: 23032970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
    Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
    Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A readily applicable strategy to convert peptides to peptoid-based therapeutics.
    Park M; Wetzler M; Jardetzky TS; Barron AE
    PLoS One; 2013; 8(3):e58874. PubMed ID: 23555603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and conformation of backbone N-aminated peptides.
    Rathman BM; Rowe JL; Del Valle JR
    Methods Enzymol; 2021; 656():271-294. PubMed ID: 34325790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conversion of Protein Active Regions into Peptidomimetic Therapeutic Leads Using Backbone Cyclization and Cycloscan - How to Do it Yourself!
    Rubin SJS; Tal-Gan Y; Gilon C; Qvit N
    Curr Top Med Chem; 2018; 18(7):556-565. PubMed ID: 29773063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peptide therapeutics: current status and future directions.
    Fosgerau K; Hoffmann T
    Drug Discov Today; 2015 Jan; 20(1):122-8. PubMed ID: 25450771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptidomimetics via modifications of amino acids and peptide bonds.
    Avan I; Hall CD; Katritzky AR
    Chem Soc Rev; 2014 May; 43(10):3575-94. PubMed ID: 24626261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibacterial evaluation of structurally amphipathic, membrane active small cationic peptidomimetics: synthesized by incorporating 3-amino benzoic acid as peptidomimetic element.
    Lohan S; Cameotra SS; Bisht GS
    Eur J Med Chem; 2014 Aug; 83():102-15. PubMed ID: 24953028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel platform for the preparation of synthetic orally active peptidomimetics with hemoregulating activity. II. Hemosuppressor activity of 2,5-diketopiperazine-based cyclopeptides.
    Deigin V; Ksenofontova O; Yatskin O; Goryacheva A; Ignatova A; Feofanov A; Ivanov V
    Int Immunopharmacol; 2020 Apr; 81():106185. PubMed ID: 32058926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of amidine-type peptide bond isosteres: application of nitrile oxide derivatives as active ester equivalents in peptide and peptidomimetics synthesis.
    Inokuchi E; Yamada A; Hozumi K; Tomita K; Oishi S; Ohno H; Nomizu M; Fujii N
    Org Biomol Chem; 2011 May; 9(9):3421-7. PubMed ID: 21423919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic carbo-isosteric depsipeptides and peptides as a novel class of peptidomimetics.
    Guéret SM; Meier P; Roth HJ
    Org Lett; 2014 Mar; 16(5):1502-5. PubMed ID: 24571727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vipegitide: a folded peptidomimetic partial antagonist of α2β1 integrin with antiplatelet aggregation activity.
    Momic T; Katzhendler J; Shai E; Noy E; Senderowitz H; Eble JA; Marcinkiewicz C; Varon D; Lazarovici P
    Drug Des Devel Ther; 2015; 9():291-304. PubMed ID: 25609915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limiting Assumptions in the Design of Peptidomimetics.
    Marshall GR; Ballante F
    Drug Dev Res; 2017 Sep; 78(6):245-267. PubMed ID: 28875546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promising Antibiofilm Activity of Peptidomimetics.
    Gomes Von Borowski R; Gnoatto SCB; Macedo AJ; Gillet R
    Front Microbiol; 2018; 9():2157. PubMed ID: 30271394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptidomimetics via copper-catalyzed azide-alkyne cycloadditions.
    Angell YL; Burgess K
    Chem Soc Rev; 2007 Oct; 36(10):1674-89. PubMed ID: 17721589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Annotation of Peptide Structures Using SMILES and Other Chemical Codes-Practical Solutions.
    Minkiewicz P; Iwaniak A; Darewicz M
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tailoring peptidomimetics for targeting protein-protein interactions.
    Akram ON; DeGraff DJ; Sheehan JH; Tilley WD; Matusik RJ; Ahn JM; Raj GV
    Mol Cancer Res; 2014 Jul; 12(7):967-78. PubMed ID: 24642350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-penetrating proline-rich peptidomimetics.
    Farrera-Sinfreu J; Giralt E; Royo M; Albericio F
    Methods Mol Biol; 2007; 386():241-67. PubMed ID: 18604949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.